EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 · Journal of Hepatology · 5,359 citations
https://doi.org/10.1016/j.jhep.2017.03.021
T
Thomas Berg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.6K
Papers
55.5K
Citations
109
h-index
558
i10-index
Thomas Berg is an academic researcher from University of Nottingham. The author has contributed to research in topics: Hepatitis C virus research & Liver Disease Diagnosis and Treatment & Hepatitis B Virus Studies. The author has an h-index of 109, co-authored 1346 publications.
ORCID: 0000-0003-0003-6241Papers by this author
worksObeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
2020 · Journal of Hepatology · 478 citations
https://doi.org/10.1016/j.jhep.2020.06.013
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis
2007 · Nature Genetics · 432 citations
https://doi.org/10.1038/ng.2007.44
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
2021 · Journal of Hepatology · 383 citations
https://doi.org/10.1016/j.jhep.2021.11.006
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
2019 · Journal of Hepatology · 346 citations
https://doi.org/10.1016/j.jhep.2019.11.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat